Of the multitude of problems associated with developing new antibiotics, finding a way to provide financial incentives to companies doing the research is especially crucial. This is because antibiotics are not used like other drugs.
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
